SeaStar Medical Holding Corp

SeaStar Medical Holding Corporation, formerly LMF Acquisition Opportunities Inc. (Nasdaq: LMAO), is a healthcare and medical device SPAC that completed its business combination with SeaStar Medical, Inc. in November 2022, with this 8-K filed on November 4, 2022 marking the close of that transaction. The blank-check company was sponsored by an affiliate of LM Funding America, Inc. and completed its initial public offering in 2021. SeaStar Medical develops the Selective Cytopheretic Device, a therapeutic platform designed to treat acute inflammatory conditions, and the post-merger combined company trades on Nasdaq under the ticker ICU. Sign up at SpacDesk for full filing history, deal analytics, and real-time data on this and every other SPAC transaction.